Bazedoxifene Acetate

CHEMBL2106615 Phase 4 Approved Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
530.7 g/mol
LogP
Phase
4

The acetate salt of bazedoxifene, an SERM used to prevent postmenopausal osteoporosis by slowing bone loss. When combined with conjugated estrogens, it treats vasomotor symptoms while protecting the uterine lining.

Molecular Weight

530.7000 g/mol

TPSA

95.20 Ų

Therapeutic Areas

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Structure

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC(=O)O.Cc1c(-c2ccc(O)cc2)n(Cc2ccc(OCCN3CCCCCC3)cc2)c2ccc(O)cc12

InChI

InChI=1S/C30H34N2O3.C2H4O2/c1-22-28-20-26(34)12-15-29(28)32(30(22)24-8-10-25(33)11-9-24)21-23-6-13-27(14-7-23)35-19-18-31-16-4-2-3-5-17-31;1-2(3)4/h6-15,20,33-34H,2-5,16-19,21H2,1H3;1H3,(H,3,4)

Molecular Formula

C32H38N2O5

HBD / HBA

3 / 6

Rotatable Bonds

7

Heavy Atoms

39

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Frequently Asked Questions

The acetate salt of bazedoxifene, an SERM used to prevent postmenopausal osteoporosis by slowing bone loss. When combined with conjugated estrogens, it treats vasomotor symptoms while protecting the uterine lining.

Yes, Bazedoxifene Acetate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2106615. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 154256. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Medical Disclaimer

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.